What were the main outcomes of the latest CONNECT clinical trial?

The study reported increased whole-brain myelination, including a sustained 26% improvement at 24 months; increased myelination in specific brain regions; a 13% increase in gray-matter volume; fewer night awakenings; increased daytime sleep; improved aspects of sociability; and a link between first-year myelination and motor development.